Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.

Anna-Lisa Oechsle Markus Hufnagel Maren Doenhardt Natalie Diffloth Horst Schroten Ruediger Von Kries Reinhard Berner Jakob Peter Armann

Published in: European journal of pediatrics (2022)

• We provide risk estimates for hospitalization for COVID-19-related treatment, ICU admission, death from COVID-19, and PIMS-TS for children with SARS-CoV-2 infections by pooling different data sources. • The risk for PIMS-TS exceeds the risk for severe COVID-19 in all age groups; the risk for severe COVID-19 is the lowest in 5-11 years old.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
emergency department
young adults
early onset
machine learning
metabolic syndrome
electronic health record
skeletal muscle
drug induced
artificial intelligence
combination therapy
glycemic control